Drug Approval | April 14, 2026
CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
A brand from Opella will be part of the official NASA astronaut formulary
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The license is valid for five years, effective from April 9, 2026
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Subscribe To Our Newsletter & Stay Updated
